![](https://weeklysauce.com/wp-content/uploads/2017/11/fda.jpg)
Offering both the promise of better patient compliance with health care, but also fears of a medical “Big Brother,” a newly approved “digital pill” allows physicians to track whether or not it’s been ingested by patients. The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia,… read on >